Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Indications for Cardiac Pacemaker Implantation in Myotonic Dystrophy.

Hawley1, Colleran, Fletcher

  • 1Georgetown University Medical School.

Medgenmed : Medscape General Medicine
|December 5, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medical Planning for Modern War.

Academic medicine : journal of the Association of American Medical Colleges·2001
Same author

OGS/Glaxo biomarker deal.

Nature biotechnology·2001
Same author

Catalytic DNA lead probe.

Nature biotechnology·2001
Same author

Blood into brains.

Nature biotechnology·2001
Same author

2,4,6-Trichlorophenylisonitrile and 2,4,6-trichlorobenzonitrile

Acta crystallographica. Section C, Crystal structure communications·2000
Same author

Efforts to commercialize structural genomics may be limited

Nature biotechnology·2000

Patients with myotonic dystrophy and prolonged PR intervals (over 275 msec) face high risks of cardiac events. Regular electrocardiograms are crucial for early detection and management of myotonic dystrophy heart disease.

Area of Science:

  • Cardiology
  • Neurology
  • Genetics

Background:

  • Myotonic dystrophy is a genetic disorder that impacts the cardiac conduction system.
  • Cardiac pacemakers offer life-saving interventions for severe heart block.
  • Understanding risk factors is key for managing myotonic dystrophy heart disease.

Purpose of the Study:

  • Identify risk factors for cardiac complications in myotonic dystrophy patients.
  • Evaluate the efficacy of permanent cardiac pacemakers for myotonic dystrophy heart disease.

Main Methods:

  • Studied 94 myotonic dystrophy patients, with 46 followed for an average of 6.4 years.
  • Monitored for endpoint events: sudden death, Stokes-Adams attacks, and atrial fibrillation onset.
  • Analyzed PR interval duration as a predictor of cardiac events.

Related Experiment Videos

Main Results:

  • Four of five patients with PR intervals >275 msec experienced adverse cardiac events.
  • All patients over 60 with PR intervals >275 msec had adverse events.
  • Only one patient with a PR interval <275 msec experienced events, which responded to pacemaker implantation.

Conclusions:

  • A prolonged PR interval (>275 msec) is a significant risk factor for cardiac complications in myotonic dystrophy.
  • Yearly electrocardiograms are recommended for myotonic dystrophy patients, especially those with prolonged or increasing PR intervals.
  • Pacemakers may be beneficial for symptomatic patients with myotonic dystrophy heart disease.